Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cloud DX Inc V.CDX.H

Alternate Symbol(s):  CDXFF

Cloud DX Inc. is a Canada-based remote patient monitoring company that is a Health Canada licensed, United States Food and Drug Administration registered medical device manufacturer and software developer offering a complete end-to-end virtual healthcare platform called Cloud DX Connected Health. The Company has developed and cleared through regulatory agencies a family of proprietary medical... see more

TSXV:CDX.H - Post Discussion

Cloud DX Inc > Hard to get excited over the Financial Statements
View:
Post by laurencelefou on Aug 27, 2022 11:32am

Hard to get excited over the Financial Statements

I like Cloud DX business model, but the current Financial Statements are not so good.

Current assets are $1,176,956.

Current liabilities are $4,235,282.

Trade receivables are $349,037.

Accounts payable are $3,430,647.

As a rule, I do not invest in companies with negative working capital.

YOY revenue growth is slightly negative.

Comprehensive lost for the quarter is $2,288,287.

Cash on the balance sheet is $19,301.

On July 6, 2022, Cloud DX received $1,970,000 from a financing deal.  That is not enough cash to cover Q2 accounts payable of  $3,430,647.

Cloud DX is signing new clients and partners, but so far, sales have not increased.

At this time, it is unclear when the company will be profitable.
Comment by lscfa on Aug 27, 2022 3:00pm
  Subscription revenue has been flat due to clients using the service for only short periods for patients. e.g. post surgery at home monitoring. As co. gets more clients with chronic care patients onboard the subscription revenue will be recurring for lengthier periods and grow. 75% margin too.       Subscription rev ...more  
Comment by lscfa on Aug 27, 2022 7:33pm
p.s. The integration of Teledoc's chronic care mgmt software should make Cloud DX's SAAS more attractive to Maxwell's clients who have 25,000 eligible patients. Patients should be long term and revenue recurring.  25,000 x $900/yr = $22,5 million annual revenue, 75% margin
Comment by Stocker46 on Aug 29, 2022 12:41pm
Bought shares last friday morning & sold this morning. Nice little profit. Looked at their financials on Sedar before their NR ... not impressed .. will track & get back in if & when they show positive signs going forward. Definitely has potential.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities